MoneyWorks4Me

The revenue for the September 2023 quarter is pegged at Rs. 1559.88 millions, about 10.94% up against Rs. 1406.12 millions recorded during the year-ago period.A humble growth in net profit of 16.62% reported in the quarter ended September 2023 to Rs. 276.54  millions from Rs. 237.12 millions.Operating Profit saw a handsome growth to 398.42 millions from 345.93 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1559.88 1406.12 10.94 2916.07 2640.83 10.42 5103.09 4720.79 8.10
Other Income 86.95 56.85 52.95 163.86 121.80 34.53 224.84 99.98 124.88
PBIDT 398.42 345.93 15.17 682.48 580.00 17.67 1116.50 1054.68 5.86
Interest 3.94 1.39 183.45 8.09 5.50 47.09 20.29 14.51 39.83
PBDT 394.48 344.54 14.49 674.39 574.50 17.39 1096.21 1040.17 5.39
Depreciation 25.80 24.22 6.52 51.25 44.91 14.12 91.66 80.88 13.33
PBT 368.68 320.32 15.10 623.14 529.59 17.66 1004.55 959.29 4.72
TAX 92.14 83.20 10.75 156.47 142.34 9.93 275.56 265.74 3.70
Deferred Tax 6.04 1.65 266.06 15.27 1.39 998.56 15.86 7.20 120.28
PAT 276.54 237.12 16.62 466.67 387.25 20.51 728.99 693.55 5.11
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 25.54 24.60 3.82 23.40 21.96 6.56 21.88 22.34 -2.07
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..